PCOS Market Analysis and Reports | USA Conference Series

Market Analysis - PCOS 2017

PCOS 2017 is expected to offer the best platform for the expertise, researchers, students and business  delegates  with its well organized scientific program covering every minute detail about  Polycystic ovary syndrome (PCOS) is a true syndrome, from the basic causes behind PCOS disease to the latest trends in diagnostic and treatment of PCOS disease. This international event is an effort to find a weapon against Endocrine disorders   being a heterogeneous collection of signs and symptoms that gathered together form a spectrum of a disorder with a mild presentation in some, whilst in others there is a severe disturbance of reproductive, endocrine and metabolic function. There has been much debate about phenotype and, more recently, genotype. There has also been   scepticism in some quarters, with a feeling that we may be looking at one end of a spectrum that is in reality `normal', or perhaps a consequence of the modern disease of obesity. Whilst the polycystic ovary is at the centre of the syndrome, it is external effects such as   hyperinsulinism that influence its expression.  There is no consensus on the definition of   PCOS   and so studies that compare epidemiology and treatments often have very different starting points, and so cannot be compared.  Which give a better insight about the associated causes and   disease portfolio.

Conference Series LLC welcomes all   the Obstetrics Gynecologists, Reproductive Endocrinologist, pathologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed PCOS 2017

Why San Antonio (USA)?

San Antonio officially the City of San Antonio, is the seventh most populated city in the United States of America and the second most populated city in the state of Texas, with a population of 1,409,019. Greater San Antonio, the metropolitan area has a population of over 2.27 million based on the 2013 US Census estimate, making it the 25th-largest metropolitan area in the United States and third-largest in the state of Texas. The city is located in the American Southwest, the south–central part of Texas, and the southwestern corner of an urban region known as the Texas Triangle. The Alamo Mission in San Antonio ("the Alamo") located in Downtown, is Texas' top tourist attraction. Because of the mission, San Antonio is often called the "Alamo City". The River Walk, which meanders through the Downtown area, is the city's second-most-visited.

Why to attend???

In today's economic climate your business decisions are as crucial as ever. Polycystic Ovarian Syndrome Conference allows you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. 3rd World Congress on Polycystic Ovarian Syndrome Conference is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading specialists involved in Polycystic Ovarian Syndrome   and Endocrine disorders. Your organization will benefit with excellent exposure to the leaders in Obstetrics Gynecologists and Metabolic disorders. PCOS-2017 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Major Polycystic Ovarian Syndrome Related Associations around the Globe :

Androgen Excess and Polycystic Ovary Syndrome(AE-PCOS)Society

Endocrine Society (USA)

American Dietetic Association

American Society Reproductive Medicine

American Association Of Clinical Endocrinologists

The European Society of Human Reproduction and Embryology

Australian Breastfeeding  Association

Polycystic Ovary Syndrome Association of Australia

The Association of UK Dietitians

Canadian Fertility and Andragogy Society Polycystic Ovarian Syndrome Association

Association for Fertility and Reproductive Health, Nigeria

Target Audience:

Obstetrics and Gynecologists, Reproductive Endocrinologist & Infertility, Womens Health CareReproductive System & Sexual Disorders, Academicians, Clinicians, Researchers, Physical therapists, Health care professionals, students, business delegates and Young researchers.

Companies associated with PCOS in Global:

  •      Sanofi
  •      Novartis AG
  •      Teva Pharmaceutical Industries Limited 
  •      Addex Therapeutics Ltd. 
  •       BIOCAD
  •       Merck KGaA
  •       AstraZeneca plc.
  •      Bristol Myers Squibb Co. 
  •       Ferring Pharmaceuticals, Inc.
  •       Crinetics Pharmaceuticals, Inc

Market Value in US million dollars for Polycystic Ovarian Syndrome Research

The global PCOS drugs market has been segmented into five major regions namely North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. In terms of value, North America and Europe are estimated to dominate the market, collectively accounting for 57% share of the overall market by the end of 2017. Latin America and Asia Pacific are estimated to be the fastest growing emerging markets. Revenue from the APAC market is expected to expand at a robust CAGR of 5.5% during the forecast period.

Global Data estimates that the global PCOS therapeutics market was valued at $656m in 2010, and is expected to grow at a static Compound Annual Growth Rate (CAGR) of 2.6% over the next eight years, to reach $804m by 2018. The growing treated population which is mainly due to expanding prevalence of co-morbid conditions such as diabetes, obesity and dyslipidemia will drive steady growth in PCOS therapeutics market.

Market Growth of Polycystic Ovarian Syndrome Research

The Polycystic Ovarian Syndrome Market Will Start Growing From 2013 Due To the Increase in Disease Prevalence and Prescription Rates and Will Rise to $702m In 2019. The global market for PCOS drugs is on an upward swing given the increasing number of cases of patients inflicted with the disease. The global polycystic ovary syndrome drugs market revenue is estimated to reach US$ 1,154.8 Mn by 2024, expanding at a CAGR of 4.6% during the forecast period (2016–2024).

 

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://pcosa.conferenceseries.com/sponsors.php

References:

  1. http://www.prnewswire.com/news-releases/polycystic-ovarian-syndrome-pcos-therapeutics---pipeline-assessment-and-market-forecasts-to-2018-132680453.html
  2. http://en.wikipedia.org/wiki/Metformin
  3. https://www.google.co.in/?gfe_rd=cr&ei=D4HUVIOrB6XV8geijYGQAw&gws_rd=ssl#q=TOP+universities+polycystic+ovarian+syndrome+in+USA
  4. https://www.google.co.in/?gfe_rd=cr&ei=D4HUVIOrB6XV8geijYGQAw&gws_rd=ssl#q=TOP+universities++of+polycystic+ovarian+syndrome+in+world+wide&start=10
  5. http://www.lef.org/Protocols/Female-Reproductive/Polycystic-Ovary-Syndrome/Page-01
  6. http://pcoshealthcoach.com/pcos-diet-grocery-shopping-on-a-budget-my-top-tips
  7. http://www.aafp.org/afp/2003/0815/p697.html